Biostar Pharmaceuticals (BSPM) Reports Q2 Earnings of $0.20, Reaffirms Guidance

Article Stock Quotes (1) Comments (0)

Biostar Pharmaceuticals (NASDAQ: BSPM) reported Q2 non-GAAP EPS of $0.20, versus $0.21 reported last year. Revenue for the quarter came in at $25.9 million, versus $19.4 million reported last year.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
• iSoftStone Holdings (ISS) Tops Q1 EPS by 1c; Guides Q2, FY13
• Wal-mart (WMT) Posts Q1 EPS of $1.14; U.S. Comps Down 1.4%; Guides Q2 EPS

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?